ELI LILLY & Co financial data

Symbol
LLY on NYSE
Industry
Pharmaceutical Preparations
Location
Lilly Corporate Ctr, Drop Code 1094, Indianapolis, IN
State of incorporation
IN
Fiscal year end
December 31
Former names
LILLY ELI & CO (to 10/25/2019), LILLY ELI & CO ET AL (to 10/14/1994)
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 115 % +2.56%
Quick Ratio 26.4 % +5.47%
Return On Equity 64.7 % +44.5%
Return On Assets 12.2 % +31.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 949M shares +0%
Entity Public Float 398B USD +45.2%
Common Stock, Value, Issued 594M USD +0.05%
Weighted Average Number of Shares Outstanding, Basic 901M shares +0.13%
Weighted Average Number of Shares Outstanding, Diluted 905M shares +0.58%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 40.9B USD +27.4%
Research and Development Expense 8.14B USD +16.4%
Nonoperating Income (Expense) 12.5M USD -94.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 10.2B USD +65.3%
Income Tax Expense (Benefit) 1.78B USD +54.3%
Net Income (Loss) Attributable to Parent 8.37B USD +67.8%
Earnings Per Share, Basic 9.29 USD/shares +67.7%
Earnings Per Share, Diluted 9.25 USD/shares +67.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.37B USD +41.5%
Accounts Receivable, after Allowance for Credit Loss, Current 10.3B USD +26.1%
Inventory, Net 7.46B USD +52.2%
Other Assets, Current 135M USD
Assets, Current 31.4B USD +36.5%
Deferred Income Tax Assets, Net 7.39B USD +61.6%
Property, Plant and Equipment, Net 16.2B USD +36.3%
Intangible Assets, Net (Excluding Goodwill) 6.54B USD -3.6%
Goodwill 5.77B USD +41.2%
Other Assets, Noncurrent 5.12B USD +4.27%
Assets 75.6B USD +30.5%
Accounts Payable, Current 2.89B USD +18.5%
Employee-related Liabilities, Current 1.7B USD +38.1%
Liabilities, Current 24.7B USD +12.2%
Accrued Income Taxes, Noncurrent 3.88B USD +11.8%
Deferred Income Tax Liabilities, Net 87.3M USD -95%
Other Liabilities, Noncurrent 2.24B USD +17.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.27B USD -12.9%
Retained Earnings (Accumulated Deficit) 13.6B USD +32.2%
Stockholders' Equity Attributable to Parent 14.2B USD +26.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 14.3B USD +26.6%
Liabilities and Equity 75.6B USD +30.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.17B USD -32.6%
Net Cash Provided by (Used in) Financing Activities -311M USD -176%
Net Cash Provided by (Used in) Investing Activities -1.18B USD -71%
Common Stock, Shares Authorized 3.2B shares 0%
Common Stock, Shares, Issued 950M shares -0.09%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -358M USD -124%
Deferred Tax Assets, Valuation Allowance 914M USD +17.9%
Deferred Tax Assets, Gross 10.3B USD +27.9%
Operating Lease, Liability 1.11B USD +52.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 7.88B USD +43.3%
Lessee, Operating Lease, Liability, to be Paid 1.39B USD +69.1%
Property, Plant and Equipment, Gross 24B USD +17.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 180M USD +37.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 197M USD +27.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +27.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 285M USD +199%
Lessee, Operating Lease, Liability, to be Paid, Year Three 154M USD +33.7%
Deferred Tax Assets, Operating Loss Carryforwards 527M USD -15.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.4B USD +13.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 138M USD +43.8%
Depreciation, Depletion and Amortization 401M USD +10.6%
Deferred Tax Assets, Net of Valuation Allowance 9.4B USD +29%
Interest Expense 563M USD +61%